Overview
Jean-luc Carre practices practicing medicine in Brest, France.
His clinical expertise encompasses Hypophosphatemia, Essential Thrombocythemia, Myeloproliferative Neoplasms (MPN), and Pheochromocytoma.
He is actively involved in clinical research, co-authoring 42 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Jean-luc L. Carre
Is Jean-luc L. Carre a top-rated expert for Hypophosphatemia?
MediFind is an objective health platform that identifies experts based on real-world data. Jean-luc L. Carre is classified as an Experienced expert for Hypophosphatemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Jean-luc L. Carre participate in research or clinical trials?
Yes. Jean-luc L. Carre has published 42 articles and abstracts on conditions like Hypophosphatemia. You can view a list of Jean-luc L. Carre's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Adrenal CancerMr. Carre isExperienced. Learn about Adrenal Cancer.
- Essential ThrombocythemiaMr. Carre isExperienced. Learn about Essential Thrombocythemia.
- HypophosphatemiaMr. Carre isExperienced. Learn about Hypophosphatemia.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Myeloproliferative Neoplasms (MPN)Mr. Carre isExperienced. Learn about Myeloproliferative Neoplasms (MPN).
- Neuroendocrine TumorMr. Carre isExperienced. Learn about Neuroendocrine Tumor.
- PheochromocytomaMr. Carre isExperienced. Learn about Pheochromocytoma.